Mesenchymal Cell News Volume 14.45 | Nov 15 2022

    0
    27








    2022-11-15 | MESCN 14.45


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.45 – 15 November, 2022
    TOP STORY

    Single-Cell Multiomics Identifies Clinically Relevant Mesenchymal Stem-Like Cells and Key Regulators for MPNST Malignancy

    Investigators uncovered a nestin-negative mesenchymal neural crest-like subpopulation as a previously unknown malignant stem-like state common to murine and human malignant peripheral nerve sheath tumor (MPNST), which correlated with clinical severity.
    [Science Advances]

    Full ArticlePress Release
    Explore tools and resources for your return to the lab
    PUBLICATIONSRanked by the impact factor of the journal

    Programmable Integrin and N-Cadherin Adhesive Interactions Modulate Mechanosensing of Mesenchymal Stem Cells by Cofilin Phosphorylation

    Scientists established a DNA-driven cell culture platform that could be programmed to present the RGD peptide from fibronectin, mimicking cell-extracellular matrix interactions, and the HAVDI peptide from N-cadherin, mimicking cell-cell interactions.
    [Nature Communications]

    Full Article

    The JNK-EGR1 Signaling Axis Promotes TNF-α-Induced Endothelial Differentiation of Human Mesenchymal Stem Cells via VEGFR2 Expression

    The authors showed that tumor necrosis factor alpha (TNF-α) promoted the endothelial differentiation of MSCs by inducing vascular endothelial growth factor receptor 2 (VEGFR2) gene expression.
    [Cell Death & Differentiation]

    Abstract

    Lipoplex-Functionalized Thin-Film Surface Coating Based on Extracellular Matrix Components as Local Gene Delivery System to Control Osteogenic Stem Cell Differentiation

    The functionalization of the multilayer with lipoplexes encapsulating DNA encoding for transient expression of bone morphogenetic protein 2 induced osteogenic differentiation of MSCs.
    [Advanced Healthcare Materials]

    Abstract

    Ganglioside GD1a Enhances Osteogenesis by Activating ERK1/2 in Mesenchymal Stem Cells of Lmna Mutant Mice

    Researchers confirmed that the expression of ganglioside GD1a was significantly reduced in MSCs derived from LmnaDhe/+ mice and in MSCs subjected to Lamin A/C knockdown using small interfering RNA.
    [Aging-Us]

    Full Article

    lncRNA HHIP-AS1/HHIP Modulates Osteogenic Differentiation of BM-MSCs by Regulating Hedgehog Signaling Pathway

    Long non-coding RNA (lncRNA) and mRNA microarrays were performed to study the change of gene expression during osteogenic differentiation of bone marrow-derived MSCs.
    [Aging-Us]

    Full Article

    Osteogenic Differentiation and Proliferation Potentials of Human Bone Marrow and Umbilical Cord-Derived Mesenchymal Stem Cells on the 3D-Printed Hydroxyapatite Scaffolds

    Investigators evaluated the proliferation and osteogenic differentiation potentials of MSCs cultured on two types of 3D-printed hydroxyapatite (HA), including a 3D-printed HA and biomimetic calcium phosphate-coated 3D-printed HA.
    [Scientific Reports]

    Full Article

    The CIt Protocol: A Blueprint to Potentiate the Immunogenicity of Immunoproteasome-Reprogrammed Mesenchymal Stromal Cells.

    Scientists found that co-administration of immunoproteasome-reprogrammed MSCs (IRMs) and interleukin-12 accentuated the anti-tumoral response, whereas the cross-presentation potency of IRMs was enhanced, delayed endosomal maturation, and increased endosome-to-cytosol plasticity.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    METTL3-Mediated Long Non-coding RNA MIR99AHG Methylation Targets miR-4660 to Promote Bone Marrow Mesenchymal Stem Cell Osteogenic Differentiation

    N6-methyladenosinemethylation in undifferentiated bone marrow MSCs was low and MIR99AHG overexpression abolished the effects of overexpressed METTL3 on promoting osteogenic differentiation.
    [Cell Cycle]

    Abstract

    Olfactory Mucosa Tissue-Derived Mesenchymal Stem Cells Lysate Ameliorates LPS-Induced Acute Liver Injury in Mice

    Olfactory mucosa-derived MSCs (OM-MSCs) were extracted and identified. The collected OM-MSCs were prepared after repeated freeze–thaw in phosphate buffer solution.
    [BMC Pulmonary Medicine]

    Full Article
    Webinar on Modeling arrhythmias using hPSC-derived cardiomyocytes
    REVIEWS

    Modification of Mesenchymal Stem Cells for Cartilage-Targeted Therapy

    Scientists review the homing effect of stem cells in joints and highlight progress toward the targeted modification of MSCs.
    [Journal of Translational Medicine]

    Full ArticleGraphical Abstract

    Inflammation in Myocardial Infarction: Roles of Mesenchymal Stem Cells and Their Secretome

    Investigators provide an overview on the current understanding of the mechanisms on MSCs and their secretome regulating inflammation and immune cells after myocardial infarction and shed light on the applications of MSCs in the treatment of cardiac infarction.
    [Cell Death Discovery]

    Full Article

    Mechanotransduction of Mesenchymal Stem Cells (MSCs) during Cardiomyocytes Differentiation

    The authors highlight MSCs in cardiovascular mechanotransduction, differentiation of cardiomyocytes, and the use of MSCs in cardiovascular disease and tissue engineering.
    [Heliyon]

    Full Article
    INDUSTRY AND POLICY NEWS

    Amniotics Led Consortium Selected for EIC-Pathfinder Grant of €3.8 Million from the European Innovation Council

    Amniotics AB announced it has been invited to finalize a grant agreement with the European Innovation Council (EIC) as part of a consortium set to receive a grant of €3,8 Million from the EIC Pathfinder program.
    [Amniotics AB]

    Press Release
    FEATURED EVENT

    Organoids as Models of Development and Disease, and Their Impact on Drug Discovery

    February 5 – 8, 2023
    Keystone, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    PhD positions – EuReCa PhD Program

    Institut Curie – Paris, France

    PhD Studentship – Pancreatic Ductal Adenocarcinoma

    Cancer Research UK Manchester Institute – Manchester, England, United Kingdom

    Postdoctoral Position – Tumor Biology

    Institute for Tumor Biology and Experimental Therapy – Frankfurt, Germany

    Postdoctoral Researcher – Stem Cell Therapy for Osteoarthritis

    NUI Galway – Galway, Ireland

    Senior Program Associate – Science in the City

    STEMCELL Technologies, Inc. – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter